- Supported exchanges /
- TW /
- 6657.TW
Energenesis Biomedical Co. Ltd. (6657 TW) stock market data APIs
Energenesis Biomedical CO.,LTD. operates in the biomedicine industry in Taiwan. It provides ENERGI-F703, which is Phase II clinical trial for use in treatment of diabetic foot ulcers; ENERGI-F701, a topical tonic for the treatment of alopecia that is in Phase II clinical trial; ENERGI-F711, a burn cream; ENERGI-F702 to treat metabolic diseases; ENERGI-F704 for the treatment of inflammatory bowel disease; ENERGI-F708 for asthma treatment; ENERGI-F705 for Parkinson's disease control; ENERGI-F707 for the treatment of mitochondria deficiency; ENERGI-F706 to treat cachexia; ENERGI-F709, a vaccine adjuvant; and ENERGI-F710 for blood phosphate control. The company also offers scientific products, which include western blot, cell culture supplement, protein isolation, protein quantification, dyes, and buffer solutions. Energenesis Biomedical CO.,LTD. was founded in 2012 and is based in Taipei, Taiwan.
Energenesis Biomedical Co. Ltd. Financial Data Overview
| 54.4 | |
| 52.3 | |
| - | |
| 54.4 | |
| 52.3 | |
| 45.9-68.5 | |
| 4 161 M | |
| 76 494 K | |
| 6 778 K | |
| 0.575 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Energenesis Biomedical Co. Ltd. Fundamental Data is available in our Financial Data APIs
- Net Revenue 6 778 K
- EBITDA -198 408 992
- Earnings Per Share -3.49
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Energenesis Biomedical Co. Ltd. Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get Energenesis Biomedical Co. Ltd. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
